Death is associated with complement C3 depletion in cerebrospinal fluid of patients with pneumococcal meningitis

mBio

Volumn 3, Issue 2, 2012, Pages

  Goonetilleke, U R ^a,e   Scarborough, M ^b   Ward, S A ^a   Hussain, S ^c   Kadioglu, A ^d   Gordon, S B ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e Chemical Development R and D   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; CASPASE 3; COMPLEMENT COMPONENT C3; CREATINE KINASE BB; TRANSFERRIN;

ADULT; APOPTOSIS; ARTICLE; BINDING AFFINITY; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; CONTROLLED STUDY; DEATH; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PNEUMOCOCCAL MENINGITIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; TRANSFERRIN BLOOD LEVEL;

BACTERIA (MICROORGANISMS);

EID: 84860500083     PISSN: None     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00272-11     Document Type: Article

References (47)

1. Weisfelt M, de Gans J, van der Poll T, van de Beek D. 2006. Pneumococcal meningitis in adults: new approaches to management and prevention. Lancet Neurol. 5:332-342.
2. Gordon SB, et al. 2002. Pneumococcal disease in HIV-infected Malawian adults: acute mortality and long-term survival. AIDS 16:1409-1417.
3. Singhi P, Bansal A, Geeta P, Singhi S. 2007. Predictors of long term neurological outcome in bacterial meningitis. Indian J. Pediatr. 74: 369-374.
4. van de Beek D, de Gans J, Tunkel AR, Wijdicks EF. 2006. Communityacquired bacterial meningitis in adults. N. Engl J. Med. 354:44-53.
5. Goonetilleke UR, Scarborough M, Ward SA, Gordon SB. 2010. Proteomic analysis of cerebrospinal fluid in pneumococcal meningitis reveals potential biomarkers associated with survival. J. Infect. Dis. 202:542-550.
6. Bermpohl D, et al. 2005. Bacterial programmed cell death of cerebral endothelial cells involves dual death pathways. J. Clin. Invest. 115: 1607-1615.
7. Moody DM. 2006. The blood-brain barrier and blood-cerebral spinal fluid barrier. Semin. Cardiothorac. Vasc. Anesth. 10:128-131.
8. Weber JR, Tuomanen EI. 2007. Cellular damage in bacterial meningitis: an interplay of bacterial and host driven toxicity. J. Neuroimmunol. 184: 45-52.
9. Koedel U, Scheld WM, Pfister HW. 2002. Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect. Dis. 2:721-736.
10. Marriott HM, Dockrell DH. 2006. Streptococcus pneumoniae: the role of apoptosis in host defense and pathogenesis. Int. J. Biochem. Cell Biol. 38:1848-1854.
11. Grandgirard D, et al. 2007. Pneumococcal meningitis induces apoptosis in recently postmitotic immature neurons in the dentate gyrus of neonatal rats. Dev. Neurosci. 29:134-142.
12. Nau R, Brück W. 2002. Neuronal injury in bacterial meningitis: mechanisms and implications for therapy. Trends Neurosci. 25:38-45.
13. Braun JS, et al. 2002. Pneumococcal pneumolysin and H2O2 mediate brain cell apoptosis during meningitis. J. Clin. Invest. 109:19-27.
14. Spreer A, et al. 2006. Antiinflammatory but no neuroprotective effects of melatonin under clinical treatment conditions in rabbit models of bacte- rial meningitis. J. Neurosci. Res. 84:1575-1579.
15. Alvarez XA, Sampedro C, Lozano R, Cacabelos R. 1999. Citicoline protects hippocampal neurons against apoptosis induced by brain betaamyloid deposits plus cerebral hypoperfusion in rats. Methods Find. Exp. Clin. Pharmacol. 21:535-540.
16. Braun JS, et al. 1999. Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nat. Med. 5: 298-302.
17. Zweigner J, et al. 2004. Bacterial inhibition of phosphatidylcholine synthesis triggers apoptosis in the brain. J. Exp. Med. 200:99-106.
18. Yuste J, et al. 2008. Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway. Infect. Immun. 76:3761-3770.
19. van der Flier M, Geelen SP, Kimpen JL, Hoepelman IM, Tuomanen EI. 2003. Reprogramming the host response in bacterial meningitis: how best to improve outcome? Clin. Microbiol. Rev. 16:415-429.
20. Stephens CG, Williams RC, Jr, Reed WP. 1977. Classical and alternative complement pathway activation by pneumococci. Infect. Immun. 17: 296-302.
21. Neeleman C, et al. 1999 Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H. Infect. Immun. 67:4517-4524.
22. Smith BL, Hostetter MK. 2000. C3 as substrate for adhesion of Streptococcus pneumoniae. J. Infect. Dis. 182:497-508.
23. Tuomanen E, Hengstler B, Zak O, Tomasz A. 1986. The role of complement in inflammation during experimental pneumococcal meningitis. Microb. Pathog. 1:15-32.
24. Winkelstein JA. 1984. Complement and the host's defense against the Pneumococcus. Crit. Rev. Microbiol. 11:187-208.
25. Betz AL. 1985. Epithelial properties of brain capillary endothelium. Fed. Proc. 44:2614-2615.
26. Doran KS, et al. 2005. Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. J. Clin. Invest. 115:2499-2507.
27. Ritchie RF, et al. 1999. Reference distributions for the negative acute-phase serum proteins, albumin, transferrin and transthyretin: a practical, simple and clinically relevant approach in a large cohort. J. Clin. Lab. Anal. 13:273-279.
28. Tai SS, Lee CJ, Winter RE. 1993. Hemin utilization is related to virulence of Streptococcus pneumoniae. Infect. Immun. 61:5401-5405.
29. Sodin-Semrl S, Rozman B. 2007. Beta2-glycoprotein I and its clinical significance: from gene sequence to protein levels. Autoimmun. Rev. 6:547-552.
30. Rupprecht TA, et al. 2007. Complement C1q and C3 are critical for the innate immune response to Streptococcus pneumoniae in the central nervous system. J. Immunol. 178:1861-1869.
31. Angel CS, Ruzek M, Hostetter MK. 1994. Degradation of C3 by Streptococcus pneumoniae. J. Infect. Dis. 170:600-608.
32. Gordon SB, et al. 2003. Poor potential coverage for 7-valent pneumococcal conjugate vaccine, Malawi. Emerg. Infect. Dis. 9:747-749.
33. Spudich S, et al. 2011. Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden. J. Infect. Dis. 204:753-760.
34. Seehusen DA, Reeves MM, Fomin DA. 2003. Cerebrospinal fluid analysis. Am. Fam. Physician 68:1103-1108.
35. Mitchell L, et al. 2004. Dual phases of apoptosis in pneumococcal meningitis. J. Infect. Dis. 190:2039-2046.
36. Tuomanen EI, Liu H, Hengstler B, Zak O, Tomasz A. 1985. The induction of meningeal inflammation by components of the pneumococcal cell wall. J. Infect. Dis. 151:859-868.
37. Hoffmann O, et al. 2006. Interplay of pneumococcal hydrogen peroxide and host-derived nitric oxide. Infect. Immun. 74:5058-5066.
38. Lotocki G, Alonso OF, Frydel B, Dietrich WD, Keane RW. 2003. Monoubiquitination and cellular distribution of XIAP in neurons after traumatic brain injury. J. Cereb. Blood Flow Metab. 23:1129-1136.
39. Niquet J, Seo DW, Wasterlain CG. 2006. Mitochondrial pathways of neuronal necrosis. Biochem. Soc. Trans. 34:1347-1351.
40. Coplin WM, et al. 1999. Cerebrospinal fluid creatine kinase-BB isoenzyme activity and outcome after subarachnoid hemorrhage. Arch. Neurol. 56:1348-1352.
41. Nussinovitch M, et al. 1996. Increased creatine kinase brain isoenzyme concentration in cerebrospinal fluid with meningitis. Clin. Pediatr. (Phila.) 35:349-351.
42. Royal W III, Gartner S, Gajewski CD. 2002. Retinol measurements and retinoid receptor gene expression in patients with multiple sclerosis. Mult. Scler. 8:452-458.
43. Seki N, Hattori A, Muramatsu M, Saito T. 1999. cDNA cloning of a human brain finger protein, BFP/ZNF179, a member of the RING finger protein family. DNA Res. 6:353-356.
44. Labadaridis I, et al. 2005. Chitotriosidase in neonates with fungal and bacterial infections. Arch. Dis. Child. Fetal Neonata. Med. 90: F531-F532.
45. Işman FK, et al. 2007. Cerebrospinal fluid and serum chitotriosidase levels in patients with aneurysmal subarachnoid haemorrhage: preliminary results. Turk. Neurosurg. 17:235-242.
46. Scarborough M, et al. 2007. Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N. Engl. J Med. 357:2441-2450.
47. Solassol J, et al. 2009. Serum protein signature may improve detection of ductal carcinoma in situ of the breast. Oncogene 29:550-560.